Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - paracetamol - effervescent tablet - 500mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

pliva pharma ltd - ramipril - oral tablet - 5mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - paracetamol - effervescent tablet - 500mg

Malta - inglise - Medicines Authority

aqvida gmbh - imatinib - hard capsule - imatinib 100 mg - antineoplastic agents

Malta - inglise - Medicines Authority

aqvida gmbh - imatinib - hard capsule - imatinib 200 mg - antineoplastic agents

Malta - inglise - Medicines Authority

aqvida gmbh - imatinib - hard capsule - imatinib 400 mg - antineoplastic agents

Malta - inglise - Medicines Authority

hameln rds gmbh langes feld 13, 31789 hameln, germany - imatinib - film-coated tablet - imatinib 100 mg - antineoplastic agents

Malta - inglise - Medicines Authority

hameln rds gmbh langes feld 13, 31789 hameln, germany - imatinib - film-coated tablet - imatinib 400 mg - antineoplastic agents

Iisrael - inglise - Ministry of Health

novartis israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 400 mg - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration for chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative . adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation . adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.

Nigeeria - inglise - NAFDAC (National Agency for Food and Drugs Administration and Control)

amitriptyline hydrochloride bp 25mg